BiotechTube
Home/Revance/David B. Howton
DB

David B. Howton

Chief Financial Officer

Revance

Therapeutic Areas

AestheticsNeurology

Revance Pipeline

DrugIndicationPhase
DAXXIFY®Glabellar LinesApproved
RHA® CollectionFacial AestheticsMarketed

Leadership Team at Revance

MJ
Mark J. Foley
Chief Executive Officer, Director
DS
Dustin S. Sjuts
President
RG
Roman G. Rubio, M.D.
Chief Medical Officer
TS
Tobin Schilke
Chief Operations Officer
View full Revance profile